The Duke Clinical Research Institute Principal Investigator of the CAMEO Registry, Dr. Jennifer Rymer is pleased to share a new episode of “CAMEO: Lessons Learned about Cangrelor,” a podcast where we talk provider-to-provider about the clinical application of the drug cangrelor. Episode 3, “A Conversation About Cangrelor and Treating Patients with Cardiogenic Shock,” features a conversation between CAMEO registry principal investigator Jennifer Rymer and Babar Basir, Director of Acute Mechanical and Circulatory Support at Henry Ford Hospital in Detroit. Dr. Rymer and Dr. Basir discuss the use of cangrelor and strategies for treating patients with cardiogenic shock. Tune in to hear their discussion of the pharmacologic considerations for patients with cardiogenic shock and to learn about the National Cardiogenic Shock Initiative at Henry Ford Hospital. Dr. Rymer and Dr. Basir also discuss their approach to using cangrelor in clinical practice for patients with cardiogenic shock. Future episodes will include site PI guest speakers discussing topics such as quality improvement (QI) within a registry and lessons learned throughout the QI initiative, and future manuscripts.